When is risk-reducing endocrine therapy recommended for BRCA gene mutation?

Endocrine medicines alter or block hormone signals that can encourage some breast cells to grow. A BRCA1 or BRCA2 result alone does not decide whether this treatment is suitable. The clinician considers your type of mutation, breast history, menstrual or menopausal status, other medicines, and risk-reduction choices already under discussion. This approach is different from surgery and does not remove breast tissue.

Arrange a consultation with a clinician familiar with hereditary cancer. Take your genetic report, family history, medication list, and details of prior breast biopsies or cancer treatment. Ask about expected benefits, side effects, interactions, pregnancy planning, bone health, blood-clot concerns, and monitoring. Genetic counselling can help place the result in the context of relatives and other prevention options.

Seek medical advice for a new breast or underarm change, nipple discharge, skin dimpling, or a persistent focal symptom, whether or not you take endocrine therapy. While taking a medicine, report unusual vaginal bleeding, severe leg swelling or pain, chest pain, sudden breathlessness, or a severe headache promptly. Emergency care is needed for severe breathing difficulty or signs of a stroke.

What does my specific BRCA result mean for this decision? Which medicine and schedule fit my health and life stage? What side effects should I watch for? How will you monitor me? How would pregnancy plans, contraception, or another preventive procedure affect the choice?